Abstract:Atractylenolides, comprising atractylenolide I, II, and III, represent the principal bioactive constituents of Atractylodes macrocephala, a traditional Chinese medicine. These compounds exhibit a diverse array of pharmacological properties, including anti-inflammatory, anti-cancer, and organ-protective effects, underscoring their potential for future research and development. Recent investigations have demonstrated that the anti-cancer activity of the three atractylenolides can be attributed to their influence on the JAK2/STAT3 signaling pathway. Additionally, the TLR4/NF-κB, PI3K/Akt, and MAPK signaling pathways primarily mediate the anti-inflammatory effects of these compounds. Atractylenolides can protect multiple organs by modulating oxidative stress, attenuating the inflammatory response, activating anti-apoptotic signaling pathways, and inhibiting cell apoptosis. These protective effects extend to the heart, liver, lung, kidney, stomach, intestine, and nervous system. Consequently, atractylenolides may emerge as clinically relevant multi-organ protective agents in the future. Notably, the pharmacological activities of the three atractylenolides differ. Atractylenolide I and III demonstrate potent anti-inflammatory and organ-protective properties, whereas the effects of atractylenolide II are infrequently reported. This review systematically examines the literature on atractylenolides published in recent years, with a primary emphasis on their pharmacological properties, in order to inform future development and application efforts.

Four New Eudesmane-Type Sesquiterpenoid Lactones from Atractylenolide II by Biotransformation of Rat Hepatic Microsomes

New Eudesmane-Type Sesquiterpenoids From The Processed Rhizomes Of Atractylodes Macrocephala

Atramacrolodes A‐D (1‐4), Four Undescribed Eudesmane‐type Sesquiterpenes from the Rhizome of Atractylodes macrocephala

Metabolic Stability and Metabolite Characterization of Capilliposide B and Capilliposide C by LC–QTRAP–MS/MS

Two new sesterterpenoids from Atractylodes japonica Koidz. ex Kitam

Simultaneous determination of atractylenolide II and atractylenolide III by liquid chromatography-tandem mass spectrometry in rat plasma and its application in a pharmacokinetic study after oral administration of Atractylodes Macrocephala Rhizoma extract.

Four new sesquiterpene lactones from Atractylodes macrocephala and their CREB agonistic activities

Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea.

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review

(±)‐Atrachinenins A—C, Three Pairs of Caged C 27 Meroterpenoids from the Rhizomes of Atractylodes chinensis

Metabolism of Echinacoside, a Good Antioxidant, in Rats: Isolation and Identification of Its Biliary Metabolites

Two Novel Sesquiterpenoid Glycosides from the Rhizomes of Atractylodes lancea

Microbial biotransformation of cryptotanshinone by Cunninghamella elegans and its application for metabolite identification in rat bile.

[A new sesquiterpene lactone from biological transformation of Hericium erinaceus and Artemisiae Annuae Herba]

Phytochemical and chemotaxonomic study on Atractylodes lancea

[New eudesmane sesquiterpenoids from Atractylodis Macrocephalae Rhizoma and their inhibitory activities against SREBPs]

Two new guaiane-type sesquiterpene glycosides from Atractylodes Japonica Koidz. ex Kitam

Atrachinenynes A–D, four diacetylenic derivatives with unprecedented skeletons from the rhizomes of Atractylodes chinensis

Investigation on the urinary excretion kinetics of three atractylenolides from crude and processed Atractylodis rhizoma extracts in rats by UPLC-MS/MS

Undescribed abietane-type diterpenoids and oleanane-type triterpenoids from the stem and branch of Tripterygium wilfordii

Integrative analysis of transcriptome and metabolome reveals the sesquiterpenoids and polyacetylenes biosynthesis regulation in Atractylodes lancea (Thunb.) DC.